| TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ... New England Journal of Medicine 375 (21), 2023-2036, 2016 | 840 | 2016 |
| Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia R Romee, M Rosario, MM Berrien-Elliott, JA Wagner, BA Jewell, ... Science translational medicine 8 (357), 357ra123-357ra123, 2016 | 817 | 2016 |
| Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML JE Maxson, J Gotlib, DA Pollyea, AG Fleischman, A Agarwal, CA Eide, ... New England Journal of Medicine 368 (19), 1781-1790, 2013 | 622 | 2013 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 413 | 2020 |
| Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms ST Oh, EF Simonds, C Jones, MB Hale, Y Goltsev, KD Gibbs Jr, ... Blood, The Journal of the American Society of Hematology 116 (6), 988-992, 2010 | 404 | 2010 |
| High-dimensional analysis delineates myeloid and lymphoid compartment remodeling during successful immune-checkpoint cancer therapy MM Gubin, E Esaulova, JP Ward, ON Malkova, D Runci, P Wong, ... Cell 175 (4), 1014-1030. e19, 2018 | 378 | 2018 |
| Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites ST Oh, S Kyo, LA Laimins Journal of virology 75 (12), 5559-5566, 2001 | 366 | 2001 |
| LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations A Pardanani, T Lasho, C Finke, ST Oh, J Gotlib, A Tefferi Leukemia 24 (10), 1713-1718, 2010 | 245 | 2010 |
| Brief report: chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis JJ Miner, HX Aw Yeang, JM Fox, S Taffner, ON Malkova, ST Oh, AHJ Kim, ... Arthritis & rheumatology 67 (5), 1214-1220, 2015 | 197 | 2015 |
| Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening JW Tyner, WF Yang, A Bankhead III, G Fan, LB Fletcher, J Bryant, ... Cancer research 73 (1), 285-296, 2013 | 176 | 2013 |
| Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11 ST Oh, MS Longworth, LA Laimins Journal of virology 78 (5), 2620-2626, 2004 | 162 | 2004 |
| NCCN guidelines insights: myeloproliferative neoplasms, version 2.2018 RA Mesa, C Jamieson, R Bhatia, MW Deininger, CD Fletcher, AT Gerds, ... Journal of the National Comprehensive Cancer Network 15 (10), 1193-1207, 2017 | 149 | 2017 |
| Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling DAC Fisher, CA Miner, EK Engle, H Hu, TB Collins, A Zhou, MJ Allen, ... Leukemia 33 (8), 1978-1995, 2019 | 124 | 2019 |
| ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial ST Oh, M Talpaz, AT Gerds, V Gupta, S Verstovsek, R Mesa, CB Miller, ... Blood advances 4 (18), 4282-4291, 2020 | 114 | 2020 |
| Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer D Cui Zhou, RG Jayasinghe, S Chen, JM Herndon, MD Iglesia, P Navale, ... Nature genetics 54 (9), 1390-1405, 2022 | 109 | 2022 |
| Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial J Gotlib, A Reiter, DH Radia, MW Deininger, TI George, J Panse, ... Nature medicine 27 (12), 2192-2199, 2021 | 109 | 2021 |
| Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ... The Lancet 401 (10373), 269-280, 2023 | 104 | 2023 |
| Co-evolution of tumor and immune cells during progression of multiple myeloma R Liu, Q Gao, SM Foltz, JS Fowles, L Yao, JT Wang, S Cao, H Sun, ... Nature communications 12 (1), 2559, 2021 | 99 | 2021 |
| Myeloproliferative neoplasms, version 3.2022, NCCN clinical practice guidelines in oncology AT Gerds, J Gotlib, H Ali, P Bose, A Dunbar, A Elshoury, TI George, ... Journal of the National Comprehensive Cancer Network 20 (9), 1033-1062, 2022 | 97* | 2022 |
| Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia DAC Fisher, O Malkova, EK Engle, CA Miner, MC Fulbright, ... Leukemia 31 (9), 1962-1974, 2017 | 93 | 2017 |
